ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany · Delayed Price · Currency is EUR 77.50
-3.00 (-3.73%)
At close: Nov 6, 2025
ANI Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 40.57 | -18.52 | 18.78 | -47.9 | -42.6 | -22.55 | Upgrade |
Depreciation & Amortization | 91.4 | 67.73 | 59.79 | 59.65 | 47.25 | 44.64 | Upgrade |
Loss (Gain) From Sale of Assets | 0.3 | -5.35 | - | -0.75 | -1.82 | - | Upgrade |
Asset Writedown & Restructuring Costs | 8.37 | 7.6 | - | 1.73 | 2.37 | 4.2 | Upgrade |
Loss (Gain) From Sale of Investments | -0.56 | -6.31 | - | - | - | - | Upgrade |
Stock-Based Compensation | 35.22 | 29.34 | 20.65 | 14.6 | 10.49 | 12.94 | Upgrade |
Other Operating Activities | -19.53 | 0.7 | -5.12 | -7.23 | -12.28 | -11.33 | Upgrade |
Change in Accounts Receivable | -56.19 | -21.09 | 3.36 | -36.91 | -5.55 | -23.66 | Upgrade |
Change in Inventory | -10.37 | -21.29 | -5.84 | -23.63 | 3.22 | -2.76 | Upgrade |
Change in Accounts Payable | 15.57 | 0.48 | 7.55 | 5.04 | 10.17 | -2.29 | Upgrade |
Change in Income Taxes | -3.15 | -1.42 | 11.99 | -0.16 | -7.57 | 4.98 | Upgrade |
Change in Other Net Operating Assets | 69.08 | 32.13 | 7.8 | 4.36 | -0.35 | 11.11 | Upgrade |
Operating Cash Flow | 170.72 | 64.02 | 118.96 | -31.2 | 3.32 | 15.27 | Upgrade |
Operating Cash Flow Growth | 83.77% | -46.19% | - | - | -78.24% | -66.54% | Upgrade |
Capital Expenditures | -14.99 | -16.24 | -8.87 | -8.88 | -2.56 | -6.14 | Upgrade |
Sale of Property, Plant & Equipment | - | 13.51 | - | 0.75 | 2.65 | - | Upgrade |
Cash Acquisitions | -8.2 | -401.28 | - | -0.03 | -84.49 | - | Upgrade |
Sale (Purchase) of Intangibles | -20.41 | -0.72 | -9.64 | -7.58 | -21.08 | -62.19 | Upgrade |
Investing Cash Flow | -43.6 | -404.72 | -18.51 | -15.74 | -105.48 | -68.32 | Upgrade |
Long-Term Debt Issued | - | 641.25 | - | - | 310.03 | 15 | Upgrade |
Long-Term Debt Repaid | - | -296.03 | -3 | -3 | -211.01 | -15.53 | Upgrade |
Total Debt Repaid | -6.25 | -296.03 | -3 | -3 | -211.01 | -15.53 | Upgrade |
Net Debt Issued (Repaid) | -6.25 | 345.22 | -3 | -3 | 99.02 | -0.53 | Upgrade |
Issuance of Common Stock | 15.27 | 6.49 | 89.55 | 1.46 | 71.65 | 0.62 | Upgrade |
Repurchase of Common Stock | -11.92 | -10.96 | -4.99 | -1.96 | -0.89 | -1.52 | Upgrade |
Preferred Dividends Paid | -1.56 | -1.63 | -1.63 | -1.63 | -0.19 | - | Upgrade |
Dividends Paid | -1.56 | -1.63 | -1.63 | -1.63 | -0.19 | - | Upgrade |
Other Financing Activities | -5.75 | -74.18 | -12.5 | - | - | - | Upgrade |
Financing Cash Flow | -10.22 | 264.95 | 67.44 | -5.13 | 194.6 | -1.44 | Upgrade |
Foreign Exchange Rate Adjustments | 0.73 | -0.47 | - | - | - | - | Upgrade |
Net Cash Flow | 117.63 | -76.23 | 167.89 | -52.07 | 92.43 | -54.49 | Upgrade |
Free Cash Flow | 155.73 | 47.78 | 110.09 | -40.08 | 0.77 | 9.13 | Upgrade |
Free Cash Flow Growth | 102.84% | -56.60% | - | - | -91.62% | -76.58% | Upgrade |
Free Cash Flow Margin | 18.83% | 7.78% | 22.61% | -12.67% | 0.35% | 4.38% | Upgrade |
Free Cash Flow Per Share | 7.58 | 2.47 | 6.05 | -2.46 | 0.06 | 0.76 | Upgrade |
Cash Interest Paid | 27.47 | 24.38 | 31.43 | 21.48 | 9.71 | 6.93 | Upgrade |
Cash Income Tax Paid | 18.46 | 19.06 | 1.23 | 0.29 | 10.37 | 4.98 | Upgrade |
Levered Free Cash Flow | 117.73 | 28.57 | 114.36 | -38.7 | -28.62 | -49.91 | Upgrade |
Unlevered Free Cash Flow | 138.38 | 49.28 | 136.26 | -20.94 | -21.16 | -43.99 | Upgrade |
Change in Working Capital | 14.95 | -11.19 | 24.86 | -51.3 | -0.08 | -12.63 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.